Page 36 - GTM-3-1
P. 36

Global Translational Medicine                             Immune response in humans due to COVID-19 infection






































            Figure 1. A comparison between the two pathways of infection by different strains of SARS-CoV-2. (1) The Alpha and Delta variants enter the body
            through the respiratory tract. (2) When the virus arrives at the lung parenchyma, the transmembrane protease serine 2 (TMPRSS2)-mediated entry process
            begins. The spike protein of the virus consists of S1 and S2 subunits, which bind to the angiotensin-converting enzyme 2 (ACE-2) receptor on the surface of
            the host cells. Once S2 binds to ACE-2, furin facilitates the cleavage of the S1 and S2 subunits through the activity of the cellular serine protease TMPRSS2.
            This pathway allows the SARS-CoV-2 virus to enter the cytosol of lung parenchyma cells. It must be noted that TMPRSS2 is a temperature-sensitive
            protease and is unable to function effectively in tissues with a high-temperature environment, such as the nasal passageway, which is why TMPRSS2-
            mediated entry is more efficient in the lung parenchyma compared to a high-temperature zone like the nasal passage, particularly for the Alpha and Delta
            variants of SARS-CoV-2. (3) TMPRSS2-mediated entry clears the way for cell-cell fusion, syncytium formation, and (A) viral propagation. (B) After viral
            propagation, (C) cytosolic toll-like receptors (TLR7/8) detect viral ribonucleic acid (RNA) and activate the (D) nuclear factor kappa B (NF-κβ) signaling
            pathway, activating downstream kinases. This prompts the release of (E) pro-inflammatory cytokines to combat the viral outbreak. However, SARS-CoV-2
            employs a tactful strategy to inhibit the release of pro-inflammatory cytokines through viral open reading frames (ORFs) and non-structural proteins
            (NSPs). (F) This blockade in the release of inflammatory cytokines leads to elevated levels of interferons (IFNs) in tissues, contributing to the onset of a
            devastating cytokine storm that leads to severe organ damage. In contrast, in the (1) Omicron strain, the nasal passage is affected by the SARS-CoV-2
            entry. (2) Upon entering nasal passage cells, the virus forms an endosome. (3) In the early endosome, the pH becomes highly acidic, contributing to (4) the
            activation of cathepsins, which are endosomal lysosomal cysteine proteases. (5) Cathepsins in late endosomes lead to the release of viral core into the cell
            and similarly lead to (A) viral propagation. (B) The propagating virus is subsequently released from the cell, causing SARS-CoV-2 infection. Figure adapted
                                                                   65
                                                                            66
                                                 63
                                                           64
                                                                                     67
            with modifications from Biswas et al.,  AbdelMassih et al.,  Willett et al.,  Pišlar et al.,  Kubo et al.,  Gomes et al.,  Hui et al. 61
                                    21
            has replaced the ACE-2-TMPRSS2-mediated pathway,   COVID-19 infections.  However, in the case of Omicron,
                                                                                 60
            significantly altering the pathogen’s mode of infection.   TMPRSS2’s  S1-S2  cleavage  is  severely  compromised,
            In the earlier strains, the ACE-2 receptor, abundantly   and entry predominantly occurs through the cellular
            expressed in several essential human organs, allowed   endosomal route, which relies more on cathepsins. 61,62
            the virus to enter the lung parenchyma.  Syncytial   Moreover, TMPRSS2 inactivity compromises the
                                                59
            pneumocyte development is frequently linked to severe   development of cellular syncytia, thereby greatly reducing
                                                                                        62
            SARS-CoV-2 infection. Cellular syncytia arise when a   the pathogenicity of the virion.  It is noteworthy that the
            SARS-CoV-2-infected cell has spike protein on its surface   site of infection can influence the severity of COVID-19.
            and begins  interacting  with  neighboring  cells’  ACE-2.   Studies suggest that the bronchi are more conducive to
            The creation of these cellular syncytia enables the virus   Omicron replication than lung parenchyma tissue. In
            to initiate a new life cycle and replicate more efficiently,   addition, human nasal epithelial cultures exhibit higher
            contributing to increased pathogenicity. Compared to the   Omicron replication rates than other common strains.
                                                                                                            61
            original strain, the Alpha variant produces more large-  The  lower  temperature in  the  upper  respiratory tract  is
            sized syncytia with higher fusogenicity, resulting in severe   crucial for maintaining the ideal acidic endolysosomal

            Volume 3 Issue 1 (2024)                         6                        https://doi.org/10.36922/gtm.2228
   31   32   33   34   35   36   37   38   39   40   41